Identification of novel target genes of nerve growth factor (NGF) in human mastocytoma cell line (HMC-1 (V560G c-Kit)) by transcriptome analysis

BMC Genomics

Volumn 12, Issue , 2011, Pages

  Dutta, Priyanka ^a   Koch, Alexandra ^a   Breyer, Bjoern ^a   Schneider, Heike ^a   Dittrich Breiholz, Oliver ^a   Kracht, Michael ^b   Tamura, Teruko ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; EARLY GROWTH RESPONSE FACTOR 1; IMATINIB; KRUPPEL LIKE FACTOR 2; MYC PROTEIN; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN C FOS; PROTEIN TYROSINE KINASE A; PROTEIN TYROSINE KINASE INHIBITOR; SMAD7 PROTEIN; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTOME; KLF2 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CELL DEATH; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN MASTOCYTOMA CELL LINE; NUCLEOTIDE SEQUENCE; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION; DRUG ANTAGONISM; GENETICS; MASTOCYTOMA; METABOLISM; RNA INTERFERENCE; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION PROFILING; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MASTOCYTOMA; NERVE GROWTH FACTOR; PIPERAZINES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD7 PROTEIN;

EID: 79955102863     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-12-196     Document Type: Article

References (40)

1. Kaplan DR, Miller FD. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 2000, 10(3):381-391. 10.1016/S0959-4388(00)00092-1, 10851172.
2. Auffray I, Chevalier S, Froger J, Izac B, Vainchenker W, Gascan H, Coulombel L. Nerve growth factor is involved in the supportive effect by bone marrow--derived stromal cells of the factor-dependent human cell line UT-7. Blood 1996, 88(5):1608-1618.
3. Chevalier S, Praloran V, Smith C, MacGrogan D, Ip NY, Yancopoulos GD, Brachet P, Pouplard A, Gascan H. Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells. Blood 1994, 83(6):1479-1485.
4. Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2010, 141(7):1117-1134. 10.1016/j.cell.2010.06.011, 20602996.
5. Meyer J, Rhein M, Schiedlmeier B, Kustikova O, Rudolph C, Kamino K, Neumann T, Yang M, Wahlers A, Fehse B, et al. Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, deltaTrkA. Leukemia 2007, 21(10):2171-2180. 10.1038/sj.leu.2404882, 17673903.
6. Ng YP, Cheung ZH, Ip NY. STAT3 as a downstream mediator of Trk signaling and functions. The Journal of biological chemistry 2006, 281(23):15636-15644. 10.1074/jbc.M601863200, 16611639.
7. Dijkmans TF, van Hooijdonk LW, Schouten TG, Kamphorst JT, Fitzsimons CP, Vreugdenhil E. Identification of new Nerve Growth Factor-responsive immediate-early genes. Brain research 2009, 1249:19-33. 10.1016/j.brainres.2008.10.050, 19013137.
8. Dijkmans TF, van Hooijdonk LW, Schouten TG, Kamphorst JT, Vellinga AC, Meerman JH, Fitzsimons CP, de Kloet ER, Vreugdenhil E. Temporal and functional dynamics of the transcriptome during nerve growth factor-induced differentiation. Journal of neurochemistry 2008, 105(6):2388-2403. 10.1111/j.1471-4159.2008.05338.x, 18346208.
9. Kunz D, Walker G, Bedoucha M, Certa U, Marz-Weiss P, Dimitriades-Schmutz B, Otten U. Expression profiling and Ingenuity biological function analyses of interleukin-6- versus nerve growth factor-stimulated PC12 cells. BMC genomics 2009, 10:90. 10.1186/1471-2164-10-90, 2657914, 19239705.
10. Lee KH, Ryu CJ, Hong HJ, Kim J, Lee EH. CDNA microarray analysis of nerve growth factor-regulated gene expression profile in rat PC12 cells. Neurochemical research 2005, 30(4):533-540. 10.1007/s11064-005-2688-y, 16076023.
11. Lee NH, Weinstock KG, Kirkness EF, Earle-Hughes JA, Fuldner RA, Marmaros S, Glodek A, Gocayne JD, Adams MD, Kerlavage A, et al. Comparative expressed-sequence-tag analysis of differential gene expression profiles in PC-12 cells before and after nerve growth factor treatment. Proceedings of the National Academy of Sciences of the United States of America 1995, 92(18):8303-8307. 10.1073/pnas.92.18.8303, 41145, 7667285.
12. Mayumi K, Yaoi T, Kawai J, Kojima S, Watanabe S, Suzuki H. Improved restriction landmark cDNA scanning and its application to global analysis of genes regulated by nerve growth factor in PC12 cells. Biochimica et biophysica acta 1998, 1399(1):10-18.
13. Marek L, Levresse V, Amura C, Zentrich E, Van Putten V, Nemenoff RA, Heasley LE. Multiple signaling conduits regulate global differentiation-specific gene expression in PC12 cells. Journal of cellular physiology 2004, 201(3):459-469. 10.1002/jcp.20087, 15389548.
14. Brynczka C, Merrick BA. The p53 transcriptional target gene wnt7b contributes to NGF-inducible neurite outgrowth in neuronal PC12 cells. Differentiation; research in biological diversity 2008, 76(7):795-808. 2562925, 18177422.
15. Koch A, Scherr M, Breyer B, Mancini A, Kardinal C, Battmer K, Eder M, Tamura T. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover. Oncogene 2008, 27(34):4678-4689. 10.1038/onc.2008.107, 18427551.
16. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 1988, 12(4):345-355. 10.1016/0145-2126(88)90050-1, 3131594.
17. Furitsu T, Tsujimura T, Tono T, Ikeda H, Kitayama H, Koshimizu U, Sugahara H, Butterfield JH, Ashman LK, Kanayama Y, et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993, 92(4):1736-1744. 10.1172/JCI116761, 288334, 7691885.
18. Kitayama H, Kanakura Y, Furitsu T, Tsujimura T, Oritani K, Ikeda H, Sugahara H, Mitsui H, Kanayama Y, Kitamura Y, et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 1995, 85(3):790-798.
19. Tam SY, Tsai M, Yamaguchi M, Yano K, Butterfield JH, Galli SJ. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 1997, 90(5):1807-1820.
20. Welker P, Grabbe J, Grutzkau A, Henz BM. Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 1998, 94(3):310-317. 1364247, 9771435.
21. Frost MJ, Ferrao PT, Hughes TP, Ashman LK. Juxtamembrane mutant V560GKit is more sensitive to Imatinib (STI571) compared with wild-type c-kit whereas the kinase domain mutant D816VKit is resistant. Mol Cancer Ther 2002, 1(12):1115-1124.
22. Heinrich MC, Griffith DJ, Druker BJ, Wait CL, Ott KA, Zigler AJ. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood 2000, 96(3):925-932.
23. Shelburne CP, McCoy ME, Piekorz R, Sexl V, Roh KH, Jacobs-Helber SM, Gillespie SR, Bailey DP, Mirmonsef P, Mann MN, et al. Stat5 expression is critical for mast cell development and survival. Blood 2003, 102(4):1290-1297. 10.1182/blood-2002-11-3490, 12714518.
24. Boon RA, Fledderus JO, Volger OL, van Wanrooij EJ, Pardali E, Weesie F, Kuiper J, Pannekoek H, ten Dijke P, Horrevoets AJ. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1. Arteriosclerosis, thrombosis, and vascular biology 2007, 27(3):532-539. 10.1161/01.ATV.0000256466.65450.ce, 17194892.
25. Roskoski R. Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor. Biochemical and biophysical research communications 2005, 338(3):1307-1315. 10.1016/j.bbrc.2005.09.150, 16226710.
26. Jiang J, Chan YS, Loh YH, Cai J, Tong GQ, Lim CA, Robson P, Zhong S, Ng HH. A core Klf circuitry regulates self-renewal of embryonic stem cells. Nature cell biology 2008, 10(3):353-360. 10.1038/ncb1698, 18264089.
27. Blank U, Karlsson G, Moody JL, Utsugisawa T, Magnusson M, Singbrant S, Larsson J, Karlsson S. Smad7 promotes self-renewal of hematopoietic stem cells. Blood 2006, 108(13):4246-4254. 10.1182/blood-2006-02-005611, 16917010.
28. Hall J, Guo G, Wray J, Eyres I, Nichols J, Grotewold L, Morfopoulou S, Humphreys P, Mansfield W, Walker R, et al. Oct4 and LIF/Stat3 additively induce Kruppel factors to sustain embryonic stem cell self-renewal. Cell stem cell 2009, 5(6):597-609. 10.1016/j.stem.2009.11.003, 19951688.
29. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001, 411(6835):355-365. 10.1038/35077225, 11357143.
30. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 1990, 61(2):203-212. 10.1016/0092-8674(90)90801-K, 2158859.
31. Tsuji K, Zsebo KM, Ogawa M. Murine mast cell colony formation supported by IL-3, IL-4, and recombinant rat stem cell factor, ligand for c-kit. Journal of cellular physiology 1991, 148(3):362-369. 10.1002/jcp.1041480306, 1717495.
32. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, Diemer K, Muruganujan A, Narechania A. PANTHER: a library of protein families and subfamilies indexed by function. Genome research 2003, 13(9):2129-2141. 10.1101/gr.772403, 403709, 12952881.
33. Thomas PD, Kejariwal A, Guo N, Mi H, Campbell MJ, Muruganujan A, Lazareva-Ulitsky B. Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools. Nucleic acids research 2006, (34 Web Server):W645-650. 10.1093/nar/gkl229, 1538848, 16912992.
34. Argiropoulos B, Humphries RK. Hox genes in hematopoiesis and leukemogenesis. Oncogene 2007, 26(47):6766-6776. 10.1038/sj.onc.1210760, 17934484.
35. Bourillot PY, Aksoy I, Schreiber V, Wianny F, Schulz H, Hummel O, Hubner N, Savatier P. Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog. Stem cells (Dayton, Ohio) 2009, 27(8):1760-1771. 10.1002/stem.110, 19544440.
36. Perkins AC, Cory S. Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. The EMBO journal 1993, 12(10):3835-3846. 413667, 8104786.
37. Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes & development 2007, 21(21):2762-2774.
38. Kuo CT, Veselits ML, Leiden JM. LKLF: A transcriptional regulator of single-positive T cell quiescence and survival. Science (New York, NY) 1997, 277(5334):1986-1990.
39. Schober SL, Kuo CT, Schluns KS, Lefrancois L, Leiden JM, Jameson SC. Expression of the transcription factor lung Kruppel-like factor is regulated by cytokines and correlates with survival of memory T cells in vitro and in vivo. J Immunol 1999, 163(7):3662-3667.
40. Dhamija S, Doerrie A, Winzen R, Dittrich-Breiholz O, Taghipour A, Kuehne N, Kracht M, Holtmann H. IL-1-induced post-transcriptional mechanisms target overlapping translational silencing and destabilizing elements in IkappaBzeta mRNA. The Journal of biological chemistry 2010, 285(38):29165-29178. 10.1074/jbc.M110.146365, 20634286.